Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer D Zips, K Zöphel, N Abolmaali, R Perrin, A Abramyuk, R Haase, S Appold, ... Radiotherapy and Oncology 105 (1), 21-28, 2012 | 543* | 2012 |
Positron Emission Tomography With [18F] Fluoro–2–Deoxy–D–Glucose for Diagnosis and Staging of Bile Duct Cancer R Kluge, F Schmidt, K Caca, H Barthel, S Hesse, P Georgi, A Seese, ... Hepatology 33 (5), 1029-1035, 2001 | 342 | 2001 |
Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment D Mattei, A Ivanov, C Ferrai, P Jordan, D Guneykaya, A Buonfiglioli, ... Translational psychiatry 7 (5), e1120-e1120, 2017 | 226 | 2017 |
Serotonin and dopamine transporter imaging in patients with obsessive–compulsive disorder S Hesse, U Müller, T Lincke, H Barthel, T Villmann, MC Angermeyer, ... Psychiatry Research: Neuroimaging 140 (1), 63-72, 2005 | 207 | 2005 |
Reduced α4β2*–nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease PM Meyer, K Strecker, K Kendziorra, G Becker, S Hesse, D Woelpl, ... Archives of general psychiatry 66 (8), 866-877, 2009 | 200 | 2009 |
JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps J Dukart, S Holiga, M Rullmann, R Lanzenberger, PCT Hawkins, ... Human Brain Mapping 42 (3), 555-566, 2021 | 146 | 2021 |
Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography K Kendziorra, H Wolf, PM Meyer, H Barthel, S Hesse, GA Becker, ... European journal of nuclear medicine and molecular imaging 38, 515-525, 2011 | 141 | 2011 |
99mTechnetium-Ethyl-Cysteinate-Dimer Single-Photon Emission CT Can Predict Fatal Ischemic Brain Edema J Berrouschot, H Barthel, R von Kummer, WH Knapp, S Hesse, ... Stroke 29 (12), 2556-2562, 1998 | 139 | 1998 |
Gastric bypass surgery recruits a gut PPAR-α-striatal D1R pathway to reduce fat appetite in obese rats MK Hankir, F Seyfried, CA Hintschich, TA Diep, K Kleberg, M Kranz, ... Cell metabolism 25 (2), 335-344, 2017 | 124 | 2017 |
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls H Barthel, J Luthardt, G Becker, M Patt, E Hammerstein, K Hartwig, ... European journal of nuclear medicine and molecular imaging 38, 1702-1714, 2011 | 109 | 2011 |
Reduced serotonin transporter–availability in obsessive–compulsive disorder (OCD) K Stengler-Wenzke, U Müller, MC Angermeyer, O Sabri, S Hesse European archives of psychiatry and clinical neuroscience 254, 252-255, 2004 | 109 | 2004 |
Monoamine transporter availability in Parkinson’s disease patients with or without depression S Hesse, PM Meyer, K Strecker, H Barthel, F Wegner, C Oehlwein, ... European journal of nuclear medicine and molecular imaging 36, 428-435, 2009 | 96 | 2009 |
Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1–Deficient Mice MK Hankir, M Kranz, S Keipert, J Weiner, SG Andreasen, M Kern, M Patt, ... Journal of Nuclear Medicine 58 (7), 1100-1103, 2017 | 94 | 2017 |
Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice J Weiner, M Kranz, N Klöting, A Kunath, K Steinhoff, E Rijntjes, J Köhrle, ... Scientific reports 6 (1), 38124, 2016 | 92 | 2016 |
Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder S Hesse, O Ballaschke, H Barthel, O Sabri Psychiatry Research: Neuroimaging 171 (2), 120-128, 2009 | 90 | 2009 |
Concordant pre-and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease H Barthel, W Hermann, R Kluge, S Hesse, DR Collingridge, A Wagner, ... American journal of neuroradiology 24 (2), 234-238, 2003 | 89 | 2003 |
Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging S Kaller, M Rullmann, M Patt, GA Becker, J Luthardt, J Girbardt, PM Meyer, ... European journal of nuclear medicine and molecular imaging 44, 1025-1032, 2017 | 88 | 2017 |
Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease S Tiepolt, S Hesse, M Patt, J Luthardt, ML Schroeter, KT Hoffmann, ... European journal of nuclear medicine and molecular imaging 43, 1700-1709, 2016 | 85 | 2016 |
Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter K Strecker, F Wegner, S Hesse, GA Becker, M Patt, PM Meyer, D Lobsien, ... Journal of neurology 258, 19-26, 2011 | 82 | 2011 |
The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive–compulsive disorder S Hesse, K Stengler, R Regenthal, M Patt, GA Becker, A Franke, ... International Journal of Neuropsychopharmacology 14 (5), 606-617, 2011 | 78 | 2011 |